A retrospective study assessing the use of oral factor Xa inhibitors in patients with cerebral venous thrombosis
Latest Information Update: 02 Sep 2020
At a glance
- Drugs Apixaban (Primary) ; Enoxaparin sodium (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- 02 Sep 2020 New trial record
- 26 Aug 2020 Primary endpoint (Recurrent thrombotic events while on anticoagulation) has not been met according to the results published in the annals of pharmacotherapy
- 26 Aug 2020 Results published in the Annals of Pharmacotherapy